Uihlein Richard E — SEC Form 4 filings

SEC reporting owner CIK 1694903. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-07 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
GALECTIN THERAPEUTICS INC (GALT)Director, 10% owner410

Form 4 filings — Uihlein Richard E

FiledFormIssuerReported transactionsSource
2026-08-044GALECTIN THERAPEUTICS INC (GALT)Option exercise (M): 31,825,235 @ $3 · Option exercise (M): 2,550,932 @ $4.05 · Option exercise (M) @ $95,475,705 · Option exercise (M) @ $10,331,275EDGAR
2026-01-214GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 13,158 @ $3.04 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-01-274GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 32,520 @ $1.23 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2024-02-074GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 23,256 @ $1.72 · Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1694903 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →